Literature DB >> 1445895

Cloning of the gene coding for a human receptor for formyl peptides. Characterization of a promoter region and evidence for polymorphic expression.

H D Perez1, R Holmes, E Kelly, J McClary, Q Chou, W H Andrews.   

Abstract

Recently we reported that, in HL-60 cells, transcription of the formyl peptide receptor (FPR) gene can be up- and downregulated by agents that induce differentiation of HL-60 cells into neutrophils. To begin studying the mechanisms involved in regulation of FPR gene expression, we cloned two human cDNAs and the gene coding for FPR. The genomic clone (pINF14) contained a 14.5-kb insert. A 2.7-kb EcoRI fragment was obtained from pINF14 that hybridized with an FPR open reading frame probe. The EcoRI fragment was sequenced and found to contain an intronless FPR open reading frame. Sequence alignment of the EcoRI genomic fragment with the FPR cDNA revealed that the first 31 bases of 5' untranslated FPR cDNA were not represented in the genomic fragment. Furthermore, a splicing consensus sequence was present in the genomic fragment at the site of divergence with the cDNA sequence. Restriction mapping and Southern blot analysis identified a 121-bp fragment that contained the sequence corresponding to the first 31 bases of 5' untranslated FPR cDNA. An additional (previously undescribed) 15-bp cDNA sequence in the 5' end of FPR were identified using an anchored polymerase chain reaction. This sequence was also contained in the genomic 121-bp fragment. This 121-bp fragment was located 5.2 kb (intron) upstream of the FPR open reading frame. It contained an unusual TATA box and displayed transcriptional activity in vitro and in vivo. Potential binding sites for AP-1 and glucocorticoid receptor were identified upstream of the putative TATA box.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445895     DOI: 10.1021/bi00161a044

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

Review 1.  Expression and signaling of formyl-peptide receptors in the brain.

Authors:  Fabio Cattaneo; Germano Guerra; Rosario Ammendola
Journal:  Neurochem Res       Date:  2010-11-02       Impact factor: 3.996

2.  Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils.

Authors:  Erica L Southgate; Rong L He; Ji-Liang Gao; Philip M Murphy; Masakatsu Nanamori; Richard D Ye
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

3.  Prolonged elevation of intracellular cyclic AMP levels in U937 cells increases the number of receptors for and the responses to formylmethionyl-leucylphenylalanine, independently of the differentiation process.

Authors:  T Fischer; R Zumbihl; J Armand; P Casellas; B Rouot
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

4.  Preclinical evaluation of the urokinase receptor-derived peptide UPARANT as an anti-inflammatory drug.

Authors:  Serena Boccella; Elisabetta Panza; Liliana Lista; Carmela Belardo; Angela Ianaro; Mario De Rosa; Vito de Novellis; Vincenzo Pavone
Journal:  Inflamm Res       Date:  2017-04-29       Impact factor: 4.575

5.  Regulation of human formyl peptide receptor 1 synthesis: role of single nucleotide polymorphisms, transcription factors, and inflammatory mediators.

Authors:  Heini M Miettinen
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

6.  Cell-specific transcriptional regulation of human leukotriene B(4) receptor gene.

Authors:  K Kato; T Yokomizo; T Izumi; T Shimizu
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

7.  Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor.

Authors:  S Fiore; J F Maddox; H D Perez; C N Serhan
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.